Judi Kittle Forner, Clinical Nurse Specialist - Adult Health Medicare: Accepting Medicare Assignments Practice Location: 4309 W Medical Center Dr Ste A200, Mchenry, IL 60050 Phone: 815-759-8070 Fax: 815-759-4931 |
Joan Rembacz, RN, APN, CCNS, CCRN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 4201 W Medical Center Dr, Mchenry, IL 60050 Phone: 815-759-4015 Fax: 815-759-4110 |
Jill C Benedeck, APRN, CNS Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 4305 W Medical Center Dr, Mchenry, IL 60050 Phone: 815-344-8000 Fax: 815-344-9601 |
News Archive
Expression Analysis today announced a jointly sponsored research grant for up to eight American Cancer Society Grantees to investigate and draw parallels between specific cancers and recurring mutations in specific kinases, using targeted genome sequencing.
Analysis of social media messages between care home staff on the coronavirus front line reveal their growing concerns over how to manage in the face of the virus. Thousands of Whatsapp messages between 250 care home workers during the first coronavirus wave show workers were often asking questions which went unanswered due to a lack of proper guidance.
DOR BioPharma, Inc. (DOR or the Company) (OTC Bulletin Board: DORB), a late-stage biotechnology company, announced today that it has entered into common stock purchase agreements with institutional investors totaling approximately $3.85 million. DOR's North American commercial partner, Sigma-Tau Pharmaceuticals, Inc., participated in this financing.
News coverage about the harmful effects of trans fat, combined with labeling information, may influence consumers' short-term purchases of foods high in trans fat, but is not enough to prompt shoppers to avoid these potentially artery-clogging purchases over the long term, according to a study in the May issue of the American Journal of Preventive Medicine.
A pre-competitive consortia of pharmaceutical companies, diagnostic companies, and academic associations, including the International Association for the Study of Lung Cancer, announced phase I results of the "BLUEPRINT PD-L1 IHC ASSAY COMPARISON PROJECT" at the Annual Meeting of the American Association for Cancer Research on April 19.
› Verified 9 days ago